BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30430317)

  • 1. Intrathecal nusinersen treatment for SMA in a dedicated neuromuscular clinic: an example of multidisciplinary and integrated care.
    Sansone VA; Albamonte E; Salmin F; Casiraghi J; Pirola A; Bettinelli M; Rao F; Mancini L; Tovaglieri N; Fedeli F; Stoia P; Heinen M; Cozzi V; Carraro E; Lunetta C; Di Bari A; Mercuri E;
    Neurol Sci; 2019 Feb; 40(2):327-332. PubMed ID: 30430317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy.
    Mousa MA; Aria DJ; Schaefer CM; Kaye RD; Abruzzo TA; Bernes SM; Willard SD; Riemann MC; Towbin RB
    Pediatr Radiol; 2018 Nov; 48(12):1797-1805. PubMed ID: 30022258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric SMA patients with complex spinal anatomy: Implementation and evaluation of a decision-tree algorithm for administration of nusinersen.
    Carrera-García L; Muchart J; Lazaro JJ; Expósito-Escudero J; Cuadras D; Medina J; Bosch de Basea M; Colomer J; Jimenez-Mallebrera C; Ortez C; Natera-de Benito D; Nascimento A
    Eur J Paediatr Neurol; 2021 Mar; 31():92-101. PubMed ID: 33711792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical puncture to deliver nusinersen in patients with spinal muscular atrophy.
    Veerapandiyan A; Pal R; D'Ambrosio S; Young I; Eichinger K; Collins E; Westesson PL; Kwon J; Ciafaloni E
    Neurology; 2018 Aug; 91(7):e620-e624. PubMed ID: 30006410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nusinersen Administration Via an Intrathecal Port in a 16-Year-Old Spinal Muscular Atrophy Patient with Profound Scoliosis.
    Flotats-Bastardas M; Linsler S; Zemlin M; Meyer S
    Pediatr Neurosurg; 2020; 55(1):54-57. PubMed ID: 31722365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience.
    Haché M; Swoboda KJ; Sethna N; Farrow-Gillespie A; Khandji A; Xia S; Bishop KM
    J Child Neurol; 2016 Jun; 31(7):899-906. PubMed ID: 26823478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nusinersen for older patients with spinal muscular atrophy: A real-world clinical setting experience.
    Veerapandiyan A; Eichinger K; Guntrum D; Kwon J; Baker L; Collins E; Ciafaloni E
    Muscle Nerve; 2020 Feb; 61(2):222-226. PubMed ID: 31773738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nusinersen for the treatment of spinal muscular atrophy.
    Chiriboga CA
    Expert Rev Neurother; 2017 Oct; 17(10):955-962. PubMed ID: 28884620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal delivery of nusinersen in individuals with complicated spines.
    Cartwright MS; Ward ZT; White EP; West TG
    Muscle Nerve; 2020 Jul; 62(1):114-118. PubMed ID: 32319101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-low radiation dose protocol for CT-guided intrathecal nusinersen injections for patients with spinal muscular atrophy and severe scoliosis.
    Rosiak G; Lusakowska A; Milczarek K; Konecki D; Fraczek A; Rowinski O; Kostera-Pruszczyk A
    Neuroradiology; 2021 Apr; 63(4):539-545. PubMed ID: 33512541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy.
    Chiriboga CA; Swoboda KJ; Darras BT; Iannaccone ST; Montes J; De Vivo DC; Norris DA; Bennett CF; Bishop KM
    Neurology; 2016 Mar; 86(10):890-7. PubMed ID: 26865511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal administration of nusinersen in adult and adolescent patients with spinal muscular atrophy and scoliosis: Transforaminal versus conventional approach.
    Bortolani S; Stura G; Ventilii G; Vercelli L; Rolle E; Ricci F; Bergui M; Mongini T
    Neuromuscul Disord; 2019 Oct; 29(10):742-746. PubMed ID: 31604650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nusinersen does not improve lung function in a cohort of children with spinal muscular atrophy - A single-center retrospective study.
    Heitschmidt L; Pichlmaier L; Eckerland M; Steindor M; Olivier M; Fuge I; Kölbel H; Hirtz R; Stehling F
    Eur J Paediatr Neurol; 2021 Mar; 31():88-91. PubMed ID: 33711791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-guided cervical puncture for nusinersen administration in adolescents.
    Ortiz CB; Kukreja KU; Lotze TE; Chau A
    Pediatr Radiol; 2019 Jan; 49(1):136-140. PubMed ID: 30167764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary Safety and Tolerability of a Novel Subcutaneous Intrathecal Catheter System for Repeated Outpatient Dosing of Nusinersen to Children and Adults With Spinal Muscular Atrophy.
    Strauss KA; Carson VJ; Brigatti KW; Young M; Robinson DL; Hendrickson C; Fox MD; Reed RM; Puffenberger EG; Mackenzie W; Miller F
    J Pediatr Orthop; 2018; 38(10):e610-e617. PubMed ID: 30134351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scoliosis and spinal muscular atrophy in the new world of medical therapy: providing lumbar access for intrathecal treatment in patients previously treated or undergoing spinal instrumentation and fusion.
    Labianca L; Weinstein SL
    J Pediatr Orthop B; 2019 Jul; 28(4):393-396. PubMed ID: 30932967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nusinersen in adult patients with spinal muscular atrophy: Observations from a single center.
    Moshe-Lilie O; Visser A; Chahin N; Ragole T; Dimitrova D; Karam C
    Neurology; 2020 Jul; 95(4):e413-e416. PubMed ID: 32665408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of nusinersen via paramedian approach for spinal muscular atrophy.
    Iwayama H; Wakao N; Kurahashi H; Kubota N; Hattori A; Kumagai T; Okumura A
    Brain Dev; 2021 Jan; 43(1):121-126. PubMed ID: 32773161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials.
    Darras BT; Farrar MA; Mercuri E; Finkel RS; Foster R; Hughes SG; Bhan I; Farwell W; Gheuens S
    CNS Drugs; 2019 Sep; 33(9):919-932. PubMed ID: 31420846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Complex Spine in Children with Spinal Muscular Atrophy: The Transforaminal Approach-A Transformative Technique.
    Towbin R; Schaefer C; Kaye R; Abruzzo T; Aria DJ
    AJNR Am J Neuroradiol; 2019 Aug; 40(8):1422-1426. PubMed ID: 31296522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.